Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Blueberries Medical Corp C.BBM

Alternate Symbol(s):  BBRRF

Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. The Company is focused on processing and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. It is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The Company’s subsidiaries include Blueberries Research Corporation (BRC), Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc. (BBV Labs.) and SATIN S.A.S. (SATIN). Blueberries SAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia.


CSE:BBM - Post by User

Bullboard Posts
Post by kinza1on Apr 29, 2019 6:19am
193 Views
Post# 29682074

why Blueberries

why Blueberriesthe first commercial crop expected in Quarter 3 in Colombia
in Argentina, they have a joint venture with Cannava, a state-owned company of Argentina = joint venture with the Argentinian government!!! This makes Blueberries VERY VERY interesting!
 - finalization of the EU GMP certification in Colombia this year. So they will start EXPORT and sales in Colombia within 2019.
- CEO Patricio Stocker was the CEO of Pharmacielo (8.25CAD at moment of writing).

He will replicating a similar business model as Pharmacielo, but improving it with their STRATEGIC PARTNERSHIPS and WORLDWIDE distribution concepts. Patricio Stocker has the knowledge and the important connections.And he has a very experienced team.

So this is a very fast growing NEW cannabis company with a big future. See you all in 2 - 3 - 5 years.
K.



Bullboard Posts